Sign In
Buy SPRO
$2.15
-0.0600 (-2.71%)
At Close: Jun 23, 2026
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08:32am, Tuesday, 03'rd Nov 2020
CAMBRIDGE, Mass., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializ
5 Healthcare Stocks the Experts at Aquilo Capital Management Are Buying (1 Has Gained 88% This Month)
05:28pm, Monday, 26'th Oct 2020
Marc Schneidman's Aquilo Capital Management is a San Francisco-based, healthcare-focused long/short hedge fund that was founded in 2010. The fund uses CIO Schneidman's 20 years of industry expertise i
